These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 19627018)

  • 61. Regional nodal staging with 18F-FDG PET-CT in non-small cell lung cancer: Additional diagnostic value of CT attenuation and dual-time-point imaging.
    Li M; Wu N; Liu Y; Zheng R; Liang Y; Zhang W; Zhao P
    Eur J Radiol; 2012 Aug; 81(8):1886-90. PubMed ID: 21511421
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Diagnostic value of FDG-PET for lymph node metastasis and outcome of surgery for biliary cancer.
    Kobayashi S; Nagano H; Hoshino H; Wada H; Marubashi S; Eguchi H; Takeda Y; Tanemura M; Kim T; Shimosegawa E; Hatazawa J; Doki Y; Mori M
    J Surg Oncol; 2011 Mar; 103(3):223-9. PubMed ID: 21140426
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Prospective evaluation of fluorine-18-FDG PET in presurgical staging of the axilla in breast cancer.
    Crippa F; Agresti R; Seregni E; Greco M; Pascali C; Bogni A; Chiesa C; De Sanctis V; Delledonne V; Salvadori B; Leutner M; Bombardieri E
    J Nucl Med; 1998 Jan; 39(1):4-8. PubMed ID: 9443729
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Clinical value of fluorodeoxyglucose-positron emission tomography/computed tomography in differentiation of malignant mesothelioma from asbestos-related benign pleural disease: an observational pilot study.
    Yildirim H; Metintas M; Entok E; Ak G; Ak I; Dundar E; Erginel S
    J Thorac Oncol; 2009 Dec; 4(12):1480-4. PubMed ID: 19875971
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Diagnostic value of 18F-fDG Pet/CT in the detection of the cervical lymph nodes metastasis].
    Ke Z; Liu M; Liu Y; He Z; Zhang Y; Zhang W
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2006 Mar; 20(6):243-5. PubMed ID: 16739373
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Diagnostic accuracy of 18F-2-deoxy-fluoro-D-glucose positron emission tomography for pN1 lymph nodes in patients with lung cancer.
    Nakagawa M; Hara M; Sakurai K; Ozawa Y; Mizuno A; Tamaki T; Nishio M; Shibamoto Y
    Acta Radiol; 2009 Jul; 50(6):638-44. PubMed ID: 19492198
    [TBL] [Abstract][Full Text] [Related]  

  • 67. 18F-FLT PET does not discriminate between reactive and metastatic lymph nodes in primary head and neck cancer patients.
    Troost EG; Vogel WV; Merkx MA; Slootweg PJ; Marres HA; Peeters WJ; Bussink J; van der Kogel AJ; Oyen WJ; Kaanders JH
    J Nucl Med; 2007 May; 48(5):726-35. PubMed ID: 17475960
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Optimised PET reconstruction of the head and neck area: improved diagnostic accuracy.
    Vogel WV; Wensing BM; van Dalen JA; Krabbe PF; van den Hoogen FJ; Oyen WJ
    Eur J Nucl Med Mol Imaging; 2005 Nov; 32(11):1276-82. PubMed ID: 16025276
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Evaluation of delayed additional FDG PET imaging in patients with pancreatic tumour.
    Nishiyama Y; Yamamoto Y; Monden T; Sasakawa Y; Tsutsui K; Wakabayashi H; Ohkawa M
    Nucl Med Commun; 2005 Oct; 26(10):895-901. PubMed ID: 16160649
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Determination of indication for sentinel lymph node biopsy in clinical node-negative breast cancer using preoperative 18F-fluorodeoxyglucose positron emission tomography/computed tomography fusion imaging.
    Taira N; Ohsumi S; Takabatake D; Hara F; Takashima S; Aogi K; Takashima S; Inoue T; Sugata S; Nishimura R
    Jpn J Clin Oncol; 2009 Jan; 39(1):16-21. PubMed ID: 18997183
    [TBL] [Abstract][Full Text] [Related]  

  • 71. False-Positive [18F]fluorodeoxyglucose-avid lymph nodes on positron emission tomography-computed tomography after allogeneic but not autologous stem-cell transplantation in patients with lymphoma.
    Ulaner GA; Lilienstein J; Gönen M; Maragulia J; Moskowitz CH; Zelenetz AD
    J Clin Oncol; 2014 Jan; 32(1):51-6. PubMed ID: 24248697
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Dual-time-point [18F]-FDG PET/CT in the diagnostic evaluation of suspicious breast lesions.
    Caprio MG; Cangiano A; Imbriaco M; Soscia F; Di Martino G; Farina A; Avitabile G; Pace L; Forestieri P; Salvatore M
    Radiol Med; 2010 Mar; 115(2):215-24. PubMed ID: 20017002
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Localization of primary prostate cancer with dual-phase 18F-fluorocholine PET.
    Kwee SA; Wei H; Sesterhenn I; Yun D; Coel MN
    J Nucl Med; 2006 Feb; 47(2):262-9. PubMed ID: 16455632
    [TBL] [Abstract][Full Text] [Related]  

  • 74. FDG-PET/CT for diagnosis of primary ovarian cancer.
    Kitajima K; Suzuki K; Senda M; Kita M; Nakamoto Y; Onishi Y; Maeda T; Yoshikawa T; Ohno Y; Sugimura K
    Nucl Med Commun; 2011 Jul; 32(7):549-53. PubMed ID: 21407140
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The effectiveness of 18F-FDG PET/CT combined with STIR MRI for diagnosing nodal involvement in the thorax.
    Morikawa M; Demura Y; Ishizaki T; Ameshima S; Miyamori I; Sasaki M; Tsuchida T; Kimura H; Fujibayashi Y; Okazawa H
    J Nucl Med; 2009 Jan; 50(1):81-7. PubMed ID: 19091887
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Relation between nodule size and 18F-FDG-PET SUV for malignant and benign pulmonary nodules.
    Khalaf M; Abdel-Nabi H; Baker J; Shao Y; Lamonica D; Gona J
    J Hematol Oncol; 2008 Sep; 1():13. PubMed ID: 18808716
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Standardized uptake value-based evaluations of solitary pulmonary nodules using F-18 fluorodeoxyglucose-PET/computed tomography.
    Degirmenci B; Wilson D; Laymon CM; Becker C; Mason NS; Bencherif B; Agarwal A; Luketich J; Landreneau R; Avril N
    Nucl Med Commun; 2008 Jul; 29(7):614-22. PubMed ID: 18528183
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The value of intratumoral heterogeneity of (18)F-FDG uptake to differentiate between primary benign and malignant musculoskeletal tumours on PET/CT.
    Nakajo M; Nakajo M; Jinguji M; Fukukura Y; Nakabeppu Y; Tani A; Yoshiura T
    Br J Radiol; 2015; 88(1055):20150552. PubMed ID: 26337605
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Defining PET standardized uptake value threshold for tumor delineation with metastatic lymph nodes in head and neck cancer.
    Suzuki O; Nishiyama K; Morimoto M; Hashiguchi H; Tanaka K; Nakajima A; Nakamura S; Yoshino K
    Jpn J Clin Oncol; 2012 Jun; 42(6):491-7. PubMed ID: 22547728
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Efficacy of 18-FDG PET-CT dual-phase scanning for detection of lymph node metastasis in gynecological cancer.
    Nogami Y; Banno K; Irie H; Iida M; Masugi Y; Murakami K; Aoki D
    Anticancer Res; 2015 Apr; 35(4):2247-53. PubMed ID: 25862886
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.